RVMD
Price
$38.30
Change
-$0.75 (-1.92%)
Updated
Jul 18 closing price
Capitalization
7.13B
16 days until earnings call
SPHDF
Price
$14.75
Change
-$1.15 (-7.23%)
Updated
May 28 closing price
Capitalization
224.86M
Interact to see
Advertisement

RVMD vs SPHDF

Header iconRVMD vs SPHDF Comparison
Open Charts RVMD vs SPHDFBanner chart's image
Revolution Medicines
Price$38.30
Change-$0.75 (-1.92%)
Volume$2.14M
Capitalization7.13B
Santhera Pharmaceuticals Holdings
Price$14.75
Change-$1.15 (-7.23%)
Volume$285
Capitalization224.86M
RVMD vs SPHDF Comparison Chart in %
Loading...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVMD vs. SPHDF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVMD is a Hold and SPHDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (RVMD: $38.30 vs. SPHDF: $14.75)
Brand notoriety: RVMD and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVMD: 92% vs. SPHDF: 113%
Market capitalization -- RVMD: $7.13B vs. SPHDF: $224.86M
RVMD [@Biotechnology] is valued at $7.13B. SPHDF’s [@Biotechnology] market capitalization is $224.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVMD’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 1 green FA rating(s).

  • RVMD’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHDF is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVMD’s TA Score shows that 4 TA indicator(s) are bullish while SPHDF’s TA Score has 2 bullish TA indicator(s).

  • RVMD’s TA Score: 4 bullish, 5 bearish.
  • SPHDF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, SPHDF is a better buy in the short-term than RVMD.

Price Growth

RVMD (@Biotechnology) experienced а +0.74% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

RVMD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($7.13B) has a higher market cap than SPHDF($225M). SPHDF YTD gains are higher at: 56.582 vs. RVMD (-12.437).
RVMDSPHDFRVMD / SPHDF
Capitalization7.13B225M3,171%
EBITDA-776.65MN/A-
Gain YTD-12.43756.582-22%
P/E RatioN/A2.52-
Revenue0N/A-
Total Cash2.1BN/A-
Total Debt134MN/A-
FUNDAMENTALS RATINGS
SPHDF: Fundamental Ratings
SPHDF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVMDSPHDF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 6 days ago
29%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
11%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
12%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
77%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGOIX19.700.08
+0.41%
Allspring Large Cap Core Inst
AEUDX8.830.01
+0.11%
American Century Equity Income R6
EAPDX15.93N/A
N/A
Parametric Dividend Income A
DWOCX15.33-0.02
-0.13%
BNY Mellon Research Growth C
HSMVX13.00-0.09
-0.69%
Hartford Small Cap Value R6

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with OCUL. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-1.92%
OCUL - RVMD
57%
Loosely correlated
-0.44%
CRNX - RVMD
56%
Loosely correlated
-5.78%
ERAS - RVMD
55%
Loosely correlated
+4.17%
IDYA - RVMD
52%
Loosely correlated
-2.26%
NRIX - RVMD
52%
Loosely correlated
-7.28%
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with GYRE. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then GYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
GYRE - SPHDF
82%
Closely correlated
-2.30%
HRMY - SPHDF
37%
Loosely correlated
-0.03%
SPRC - SPHDF
34%
Loosely correlated
-6.22%
INM - SPHDF
33%
Poorly correlated
+1.33%
RVMD - SPHDF
33%
Poorly correlated
-1.92%
More